Current studies have suggested that the enhancement of JAK/STAT pathway activity can promote the proliferation, growth, invasion and metastasis of ovarian cancer cells, inhibit cell apoptosis, and progress towards cisplatin resistance [22]. The gene discussed is SOAT1; the disease is ovarian carcinoma.